biology2 papersavg year 2026quality 5/5

clinical characterization targeting safety target

Research gap analysis derived from 2 biology papers in our local library.

The gap

Side effects and off-target toxicities of drugs targeting RNF20 require more in-depth exploration and adequate validation. Systematic characterization of adverse effects in normal tissues and organ systems is needed to establish the clinical safety profile of RNF20-targeting therapeutics.; Safety profiles and potential off-target effects of CD24-targeting approaches in clinical settings need comprehensive characterization

Research trend

Emerging — attention growing, methods still coalescing.

Supporting evidence — 2 representative gaps

  • Decoding RNF20: an epigenetic modifier and beyond (2026) · doi

    Side effects and off-target toxicities of drugs targeting RNF20 require more in-depth exploration and adequate validation. Systematic characterization of adverse effects in normal tissues and organ systems is needed to establish the clinical safety profile of RNF20-targeting therapeutics.

    Keywords: RNF20 targeting side-effects off-target toxicity drug safety clinical validation organ toxicity
  • CD24 as an innate immune checkpoint in solid tumors: biology, biomarker stratification, and therapeutic translation (2026) · doi

    Safety profiles and potential off-target effects of CD24-targeting approaches in clinical settings need comprehensive characterization

    Keywords: safety profiles potential target effects targeting approaches clinical settings need comprehensive characterization

Working on this gap? Publish with us.

Science AI Journal reviews manuscripts in under 15 minutes with 8 specialised AI reviewers calibrated on 23,000+ real peer reviews. Open access, CC BY 4.0.

Related gaps in biology

Command palette

Jump anywhere, run any action.